Cargando…
Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity
BACKGROUND: Acetylsalicylic acid/aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used drugs that may cause hypersensitivity reactions in a substantial proportion of patients. Physicians ought to be aware of these situations. OBJECTIVE: We aimed to present the clinical char...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asia Pacific Association of Allergy, Asthma and Clinical Immunology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402950/ https://www.ncbi.nlm.nih.gov/pubmed/32789114 http://dx.doi.org/10.5415/apallergy.2020.10.e29 |
_version_ | 1783566861363838976 |
---|---|
author | Terzioğlu, Kadriye Sancar, Özgür Ekerbiçer, Hasan Çetin Öztürk, Raziye Tülümen Epöztürk, Kürşat |
author_facet | Terzioğlu, Kadriye Sancar, Özgür Ekerbiçer, Hasan Çetin Öztürk, Raziye Tülümen Epöztürk, Kürşat |
author_sort | Terzioğlu, Kadriye |
collection | PubMed |
description | BACKGROUND: Acetylsalicylic acid/aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used drugs that may cause hypersensitivity reactions in a substantial proportion of patients. Physicians ought to be aware of these situations. OBJECTIVE: We aimed to present the clinical characteristics and rates of tolerability to cyclooxygenase (COX)-2 inhibitor analgesics in patients who had admitted due to multiple cross-reactive type of NSAID hypersensitivity. METHODS: The files of the patients who had admitted with multiple NSAIDs-induced symptoms were investigated retrospectively. Age, sex, underlying diseases, clinical manifestation, skin test results, and drug provocation test results were analyzed. RESULTS: In 105 patients with multiple cross-reactive type of NSAID hypersensitivity, we found the rate of cross-reactivity to any of the relatively safe alternatives including paracetamol, meloxicam, and nimesulide to be 16.1%. The rate of cross-reactivity to these relatively safe drugs was significantly higher in patients with a history of anaphylaxis induced by NSAID intake (p = 0.006). CONCLUSION: The diagnosis of COX-1-mediated multiple NSAID hypersensitivity can be often established with a detailed history. Although rare, severe hypersensitivity reactions may be observed in these patients. Undesired situations for both patients and physicians may be avoided by testing relatively safe paracetamol and COX-2 inhibitors in experienced centers. |
format | Online Article Text |
id | pubmed-7402950 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Asia Pacific Association of Allergy, Asthma and Clinical Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-74029502020-08-11 Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity Terzioğlu, Kadriye Sancar, Özgür Ekerbiçer, Hasan Çetin Öztürk, Raziye Tülümen Epöztürk, Kürşat Asia Pac Allergy Original Article BACKGROUND: Acetylsalicylic acid/aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used drugs that may cause hypersensitivity reactions in a substantial proportion of patients. Physicians ought to be aware of these situations. OBJECTIVE: We aimed to present the clinical characteristics and rates of tolerability to cyclooxygenase (COX)-2 inhibitor analgesics in patients who had admitted due to multiple cross-reactive type of NSAID hypersensitivity. METHODS: The files of the patients who had admitted with multiple NSAIDs-induced symptoms were investigated retrospectively. Age, sex, underlying diseases, clinical manifestation, skin test results, and drug provocation test results were analyzed. RESULTS: In 105 patients with multiple cross-reactive type of NSAID hypersensitivity, we found the rate of cross-reactivity to any of the relatively safe alternatives including paracetamol, meloxicam, and nimesulide to be 16.1%. The rate of cross-reactivity to these relatively safe drugs was significantly higher in patients with a history of anaphylaxis induced by NSAID intake (p = 0.006). CONCLUSION: The diagnosis of COX-1-mediated multiple NSAID hypersensitivity can be often established with a detailed history. Although rare, severe hypersensitivity reactions may be observed in these patients. Undesired situations for both patients and physicians may be avoided by testing relatively safe paracetamol and COX-2 inhibitors in experienced centers. Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2020-07-14 /pmc/articles/PMC7402950/ /pubmed/32789114 http://dx.doi.org/10.5415/apallergy.2020.10.e29 Text en Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology. https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Terzioğlu, Kadriye Sancar, Özgür Ekerbiçer, Hasan Çetin Öztürk, Raziye Tülümen Epöztürk, Kürşat Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
title | Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
title_full | Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
title_fullStr | Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
title_full_unstemmed | Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
title_short | Tolerability to paracetamol and preferential COX-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
title_sort | tolerability to paracetamol and preferential cox-2 inhibitors in patients with cross-reactive nonsteroidal anti-inflammatory drugs hypersensitivity |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402950/ https://www.ncbi.nlm.nih.gov/pubmed/32789114 http://dx.doi.org/10.5415/apallergy.2020.10.e29 |
work_keys_str_mv | AT terzioglukadriye tolerabilitytoparacetamolandpreferentialcox2inhibitorsinpatientswithcrossreactivenonsteroidalantiinflammatorydrugshypersensitivity AT sancarozgur tolerabilitytoparacetamolandpreferentialcox2inhibitorsinpatientswithcrossreactivenonsteroidalantiinflammatorydrugshypersensitivity AT ekerbicerhasancetin tolerabilitytoparacetamolandpreferentialcox2inhibitorsinpatientswithcrossreactivenonsteroidalantiinflammatorydrugshypersensitivity AT ozturkraziyetulumen tolerabilitytoparacetamolandpreferentialcox2inhibitorsinpatientswithcrossreactivenonsteroidalantiinflammatorydrugshypersensitivity AT epozturkkursat tolerabilitytoparacetamolandpreferentialcox2inhibitorsinpatientswithcrossreactivenonsteroidalantiinflammatorydrugshypersensitivity |